ArticleThe FEBS journal2026
Limited roles of the miR-17-92 cluster in the regulation of T-cell apoptosis.
Article in The FEBS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The pro-apoptotic BCL-2-interacting mediator of cell death [BIM; also known as Bcl-2-like protein 11 (BCL2L11)] is a crucial regulator of programmed cell death in immune cells, with roles in T-cell development, homeostasis, and immune response modulation. However, the precise molecular mechanisms that regulate BIM expression in these processes are not completely understood. One possible regulatory mechanism involves microRNAs, small noncoding RNAs that silence target messenger RNAs (mRNAs). The miR-17-92 cluster, which has been implicated in immune regulation, has nine predicted binding sites in the 3' untranslated region of the Bcl2l11 mRNA (thereafter referred to as Bim mRNA). To explore whether direct miR-17-92-mediated regulation of BIM controls apoptosis in T cells, a genetically modified mouse model with disrupted miR-17-92:Bim interactions specifically in T cells has been used. The results revealed that loss of miR-17-92:Bim binding, although leading to a modest increase of BIM protein in double-positive (DP) thymocytes and naïve CD8
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.